| Literature DB >> 35413088 |
Daniel Dalos1, Theresa Dachs1, Constantin Gatterer1, Matthias Schneider1, Thomas Binder1, Diana Bonderman1, Christian Hengstenberg1, Simon Panzer2, Stefan Aschauer1.
Abstract
BACKGROUND: Data on cardiac remodeling in veteran athletes are conflicting but of clinical importance.Entities:
Mesh:
Year: 2022 PMID: 35413088 PMCID: PMC9004772 DOI: 10.1371/journal.pone.0266951
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline characteristics.
|
|
|
|
| |
|---|---|---|---|---|
|
|
|
| ||
|
| ||||
| Age, years | 57 (52–64) | 55 (52–63) | 57 (54–66) | 0.684 |
| Female sex, n (%) | 18 (26.1) | 14 (31.0) | 4 (16.7) | 0.199 |
| Height, cm | 176 (174–177) | 175 (173–177) | 178 (174–181) | 0.164 |
| Weight, kg | 77 (74–80) | 74 (71–78) | 81 (75–86) | 0.165 |
| Body mass index, kg/m2 | 24 (23–26) | 24 (22–26) | 25 (23–27) | 0.086 |
| Heart rate, bpm | 61 (59–63) | 60 (57–63) | 63 (59–67) | 0.205 |
| Systolic blood pressure, mmHg | 127 (124–129) | 128 (125–130) | 125 (120–130) | 0.260 |
| Diastolic blood pressure, mmHg | 83 (82–84) | 83 (82–85) | 83 (81–85) | 0.825 |
| Alcohol intake, n (%) | 51 (73) | 30 (67) | 21 (88) | 0.061 |
| Current smoker, n (%) | 6 (9) | 3 (7) | 3 (13) | 0.670 |
| Exercise per week, hours | 6 (4.5–8) | 7 (6–10) | 4 (3.5–5) | < 0.001 |
|
| ||||
| Hemoglobin, g/dl | 14.7 (14.1–15.2) | 14.6 (13.8–15.2) | 15.0 (14.4–15.3) | 0.200 |
| Hematokrit, % | 42 (41–43) | 42 (40–43) | 42 (41–44) | 0.265 |
| HbA1c, % | 5.4 (5.2–5.5) | 5.4 (5.2–5.5) | 5.4 (5.2–5.6) | 0.967 |
| NT-proBNP, pg/ml | 38 (17–76) | 43 (15–74) | 33 (18–94) | 0.378 |
Continuous variables are given as medians and inter-quartile ranges. Counts are given as numbers and percentages. EAA–ambitious endurance-trained amateur athletes, NT-proBNP–N-terminal pro brain natriuretic peptide, RAP–recreationally active endurance-trained participants.
Echocardiographic analyses.
|
|
|
|
| |
|---|---|---|---|---|
|
|
|
| ||
| RA diameter, mm | 53 (49–55) | 53 (49–55) | 53 (52–58) |
|
| RA diameter-Index, mm/m2 BSA | 27 (26–29) | 27 (25–29) | 27 (25–30) | 0.989 |
| RVEDD, mm | 34 (31–37) | 34 (31–37) | 35 (32–38) | 0.336 |
| RVEDD-Index, mm/m2 BSA | 18 (16–19) | 18 (16–20) | 17 (16–19) | 0.417 |
| TAPSE, mm | 26 (23–29) | 25 (23–29) | 27 (25–29) | 0.200 |
| RV-TDI, m/sec | 0.15 (0.14–0.16) | 0.15 (0.13–0.16) | 0.16 (0.15–0.16) | 0.064 |
| Mild TR, n (%) | 18 (26) | 12 (27) | 6 (25) | 0.779 |
| TR-velocity, m/sec | 2.5 (2.3–2.8) | 2.5 (2.4–2.8) | 2.3 (2.2–2.5) |
|
| PAP systolic, mmHg | 30 (26–36) | 30 (28–36) | 25 (20–30) | 0.141 |
| LA diameter, mm | 53 (49–55) | 52 (49–55) | 53 (52–58) |
|
| LA diameter- Index, mm/m2 BSA | 27 (26–29) | 27 (25–29) | 27 (26–30) | 0.880 |
| LA volume, ml | 75 (64–82) | 75 (63–82) | 72 (65–90) | 0.842 |
| LA volume- Index, ml/m2 BSA | 39 (33–44) | 39 (34–44) | 37 (33–45) | 0.873 |
| LVEDD, mm | 50 (47–52) | 50 (47–53) | 50 (47–52) | 0.648 |
| LVEDD-Index, mm/m2 BSA | 27 (25–28) | 27 (25–28) | 25 (24–27) |
|
| Ejection fraction, % | 59 (57–63) | 59 (56–61) | 63 (58–64) |
|
| IVS, mm | 11 (10–12) | 11 (10–12) | 11 (10–12) | 0.427 |
| Relative wall thickness ratio | 0.5 (0.5–0.6) | 0.5 (0.5–0.6) | 0.6 (0.5–0.6) | 0.409 |
| Mild MR, n (%) | 23 (33) | 12 (27) | 11 (46) | 0.108 |
| E/E’ | 7 (6–9) | 7 (6–9) | 9 (7–10) |
|
| Diastolic function |
| |||
| Normal function, n (%) | 39 (57) | 28 (62) | 8 (33) | |
| Impaired relaxation, n (%) | 27 (39) | 17 (38) | 13 (54) | |
| Pseudonormal filling, n (%) | 1 (1) | 0 | 1 (4) | |
| Restrictive filling, n (%) | 2 (3) | 0 | 2 (8) | |
| Global RV strain, % | -26 (-27–-21) | -25 (-28–-22) | -26 (-27–-21) | 0.864 |
| Basal RV strain, % | -23 (-26–-20) | -23 (-26–-20) | -24 (-26–-20) | 0.543 |
| Mid RV strain, % | -26 (-27–- 21) | -25 (-28–-21) | -26 (-27–-21) | 0.883 |
| Apical RV strain, % | -27 (-30–-21) | -27 (-30–-21) | -28 (-31–-25) | 0.514 |
| Global LV strain, % | -19 (-21–-18) | -19 (-21–-17) | -19 (-21–-18) | 0.445 |
| Basal LV strain, % | -16 (-17–-14) | -16 (-17–-14) | -16 (-17–-15) | 0.714 |
| Mid LV strain, % | -18 (-19–-17) | -18 (-19–-16) | -18 (-20–-17) | 0.143 |
| Apical LV strain, % | -25 (-27–-21) | -24 (-28–-21) | -25 (-27–-22) | 0.803 |
| LA reservoir strain, % | 25 (20–31) | 27 (22–34) | 20 (15–29) |
|
Continuous variables are given as medians and inter-quartile ranges. Counts are given as numbers and percentages. EAA–ambitious endurance-trained amateur athletes, BSA–body surface area, E–early mitral inflow velocity, E’–early diastolic mitral annular velocity, IVS–interventricular septal thickness, LA–left atrium, LV–left ventricular, LVEDD–left ventricular end-diastolic diameter, MR–mitral regurgitation, PAP–pulmonary artery pressure, RA–right atrium, RAP–recreationally active endurance-trained participants, RV–right ventricular, RVEDD–right ventricular end-diastolic diameter, RV–TDI–right ventricular tissue doppler imaging, TAPSE–tricuspid annular plane systolic excursion, TR–tricuspid regurgitation, TR-velocity–tricuspid regurgitation velocity.